Fundz

Taurx Announces Additional Investment Of Usd119 Million Following Announcement Of Phase 3 Lucidity Topline Results

PRIVATENov 14, 2022

Round Type

Venture

AberdeenBiotechnologyHealth Care

Description

TauRx Pharmaceuticals Ltd is a global leader in tau-based research in Alzheimer's disease (AD). Pathological aggregation of Tau correlates with clinical disease severity and brain atrophy. It is a hallmark of the disease recognised as an important potential target for treating AD. HMTM is an oral tau aggregation inhibitor, targeting this underlying pathology.

Quick answer

TAURx PHARMACEUTICALS raised an undisclosed amount in a funding round, dated November 14, 2022. TAURx PHARMACEUTICALS is based in Aberdeen, Washington, United States.

How much did TAURx PHARMACEUTICALS raise?
TAURx PHARMACEUTICALS raised an undisclosed amount in a funding round on November 14, 2022.
What does TAURx PHARMACEUTICALS do?
TauRx was established to address one of the world’s biggest challenges – beating Alzheimer’s disease and other degenerative brain disorders through a completely new approach.
Where is TAURx PHARMACEUTICALS based and how big is it?
TAURx PHARMACEUTICALS is based in Aberdeen, Washington, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as TAURx PHARMACEUTICALS that raised within 45 days of this round, from Fundz verified event records.

  • CytoSorbents Corporation raised $5M (Debt Financing) on December 29, 2022.
  • Cue Biopharma raised an undisclosed amount on December 27, 2022.
  • TRACON raised $30M (Grant) on December 27, 2022.
  • Endovia Health Sciences, Inc. raised $4M (Seed) on December 27, 2022.
  • PVmed raised $14M (Series A) on December 23, 2022.
  • GenSight Biologics raised $13M (Convertible Note) on December 23, 2022.

Who to call at TAURx PHARMACEUTICALS, and when

A new round usually means TAURx PHARMACEUTICALS is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TAURx PHARMACEUTICALS raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TAURx PHARMACEUTICALS, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TAURx PHARMACEUTICALS. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TAURx PHARMACEUTICALS

Location

Aberdeen, Washington, United States

About

TauRx was established to address one of the world’s biggest challenges – beating Alzheimer’s disease and other degenerative brain disorders through a completely new approach. A leader in Alzheimer’s research, the company’s mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative disorders. TauRx’s strong research team, supported through cooperative relationships with multiple academic institutions around the world, has focussed on the tau pathway, believed to be one of the critical causes of neurodegeneration in the brain. The company’s novel tau aggregation inhibitors (TAIs) target the formation of tau protein ‘tangles’ in the brain, with its lead compound having shown strong pharmacological effect in early trials for participants with mild and moderate Alzheimer's disease. The experimental drug has shown to inhibit aggregation of tau, synuclein, TPD-43 and huntingtin proteins. It is currently in development for the treatment and prevention of Alzheimer’s disease, with a pivotal phase 3 clinical trial in progress and results recently disclosed. Additionally, TauRx works closely with joint venture company Genting TauRx Diagnostics Ltd (GTD) in the development of ground-breaking new diagnostic tools and blood tests for dementia, which will help transform the treatment pathway for those affected, ensure efficient and early diagnosis and enhance access to treatment and care. TauRx is incorporated in Singapore with primary research and operations in Aberdeen, Scotland.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TAURx PHARMACEUTICALS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for TAURx PHARMACEUTICALS's next move

See what Strategic adds

TAURx PHARMACEUTICALS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.